BioNanotechnology Summer Institute 2014 - Poster Session 08/06/16
Sep 5, 2023
Hi, I'm Joseph Silva, I come from the University of California, Merced, Department of Material
Science and Engineering.
My group works on solar selective coating, and solar selective coating helps reduce the
cost and improves the efficiency of current solar devices.
So in particular, we are working with low temperature solar selective materials such
as aluminum.
Aluminum is cheap and it's really easy to process, and what we're trying to prove is
that if you introduce an oxide layer to aluminum and get a nice linear rate of diffusion between
aluminum and oxygen, that you can have great light penetration and it can actually act
as a great light absorber and heater.
So currently, if you've seen those black thermal panels on people's houses, that can
get you up to about 30, 35 degrees Celsius.
That's okay for residentials, but if you want industrial grade heating, you would want
about 100 to 200 degrees Celsius, and aluminum is great because it can get really hot without
melting and it gives off a good amount of heat.
So once the light passes the oxide layer, you'll get a bulk of aluminum, and the reflectivity
properties of aluminum will keep light trapped within the material and heat your thermal,
will heat your, either whether it be water, whether it be oil, water at that temperature
would turn to steam, so a lot of companies like steam power, or you can have oil, which
can transfer the energy throughout the, wherever you want it to go, you can just pipe it through.
So currently we are using Fick's second law as a method for any given X to determine concentration
at different depths.
We have the diffusion of oxygen across the grain boundaries, and we have this diffusion
of aluminum across the grain boundaries, and as you can see here, these are, aluminum diffuses
a lot faster than oxygen, so we're trying to introduce different methods to slow down
that aluminum diffusion rate so it doesn't just push the oxygen out of the aluminum oxide
layer.
One way we're doing that is, while we're heating aluminum, we introduce sodium bicarbonate,
which once it's heated up at the diffusion rate, or the diffusion temperature of aluminum,
it gives off CO2, CO2 will help slow down that self-diffusion of aluminum.
And this is a graph of a high temperature material, but it's close to what we want
for this low temperature material.
We don't have a really great method of modeling for our material right now, that's why we're
trying to use nanoHUB to actually, and nanoHUB, we're trying to use Python as the language
we're using in nanoHUB, and we want to try and use this equation to give us a nice graph
of oxygen penetration through the aluminum.
Right now we're just using SEM scattering, scattering a light microscopy, electron microscopy,
to get the concentrations at different depths.
Different depths correspond to the different kilovolts, this is 5 kilovolts, you can see
that the aluminum to oxygen is pretty close.
At 10 kilovolts, the aluminum to oxygen, you're getting a little more aluminum, and at 15
kilovolts you're getting a lot more aluminum, which is pretty much what we want, because
we want to keep the light in as it passes that oxide layer.
Our next step is just to introduce more, some other dopants, which helps the diffusion rates
of aluminum and oxygen.
Hi, I'm Rosalind Xu, I'm from the Department of Cell and Environmental Biology here at
UIUC, the poster I'm presenting today is about the study of dynamics of ORB1 and ORB2,
or ORCA, at telomeres, and their role in DNA damage response.
Basically, both ORB1 and ORCA, there are known proteins that are involved in DNA replication
initiation, but what we're trying to address here is their additional role in the cell,
especially at telomere.
From this image, this is a previous publication from a lab, we can see, this is an immunofluorescence
image, we can see that the signal of ORCA, ORB1, actually co-localized, which is indicated
by these white spots.
So we can see that these proteins localize at telomere, and basically a protein does
not go to a place that doesn't have a function.
Besides that, we also found that the localization of these two proteins with telomere is specific
in cells that use a different mechanism for telomere lengthening, which is called alternative
lengthening of telomeres, which basically utilize homologous recombination.
Besides these evidence, reference, which indicates that both ORB1 and ORCA, they have a consensus
phosphorylation size, which indicates that they might participate in the DNA damage response
mediated by ATM and ATR, these two kinases.
So based on these evidence, the aim of this study is, the first is to study the role of
ORB1 and ORCA at telomeres, and whether they have a role in DNA damage response, and how
they interact with DNA, I will say more specifically with telomere.
And then the bottoms are several approaches that we wish to address our questions, such
as right now we're using truncated mutants to see which is the minimum domain required
for these two proteins to associate with telomere, and we also want to see whether these two
proteins directly interact with the telomere DNA sequence, or whether they interact with
the telomere-associated protein, which is the sheltering complex instead.
So this is my study.
I'm a second-year PhD student at Drexel University, working in two different labs with Dr. Kara
Kogotsi of the Nanomaterials Institute at Drexel University.
We're engineering nanomaterials, and macrophages can be divided into two different categories,
classically alternatively activated, including M2A and M2C, and they're stuck, this is because
they're stuck in the M1 phase, so they're stuck in inflammation.
You get a cut, and it just does not heal.
What I would like to do is take these people who have this cut and use a therapy targeting
macrophages to get them to go into healing state, and this would be, you know, even if
it's scar formation, it's something that closes the cut and stops the inflammation.
So I have a nanomaterial called nanodiamond.
It's interesting because it has the same properties as bulk diamond, but at a nanoscale.
It has the same chemical structure, and it's very hard.
What's interesting about it is that it's proven to be very biocompatible, and also has very
rich surface chemistry, which is strange because we usually think of diamond as being very inert.
So it actually, as you can see here, has lots of carboxylic acid groups and hydroxyl groups
on the surface.
We can do a lot of surface treatments, such as purification to increase the number of
carboxylic acid groups, or we can do amination.
So over here I have pictures of two types of modified diamond.
This one is modified with octadecyl amine.
What's really strange about this is that it's blue and hydrophobic.
So neither of the diamonds have this blue hydrophobic particle.
It was physiosorb rhodamine on the surface, and this rhodamine is called tapazine.
It was only found by NTU looking at using nanoparticles and macrophages.
What I do do is investigate a drug called dexamethasone and its effect on macrophages.
Since this is my personal start to the field of biology, we took PHB1 cells, which are
a type of monocytic cell line derived from a French macrophage.
These three different phenotypes, M1, M2A, and M2C, using a procedure found in steroids,
are known to decrement.
So we wanted to see if inducing a propylene response, in addition to decreasing inflammation,
would prevent it.
So we used RT-PCR to quantify this using known gene markers for the three different major
types of macrophage phenotypes.
But we did find, you can see this M1 here actually switches.
It has an upregulation of CD163 and actually switches to the M2C phenotype.
So this is an increase in the regulatory behavior.
In the future, I would like to put this drug onto the diamond surface and look at a couple
of different techniques to look at how drug is taken up by the macrophage.
Is it receptor-mediated endocytosis, which is how most cells take up the drug?
Or is it phagocytosis?
You can think of macrophages like Pac-Man.
They just go in and they eat everything.
The adsorption and desorption properties of that drug onto diamonds.
They characterize the phenotype using different types of human macrophages so that it becomes
biologically relevant.
I'm Claire McGee.
I'm from the University of Illinois and I work in Professor Yi Liu's lab.
Basically, what I'm going to be talking about today is using a glucose meter to monitor
something else like lithium in this case.
Now, the reason I wanted to monitor something like lithium is because lithium is used to
treat bipolar disorder for about 23% of patients.
And it's used specifically to depress the manic state.
So one of the problems with using lithium is that it has a very small therapeutic window.
So it's about 0.5 millimolar to 1.2 millimolar in serum.
Above that, we see toxic effects.
And below that, it's not effective.
And so we want to monitor this drug.
And also, lithium's role in reducing the manic state is not completely known.
So if we could do cellular studies, that would also help us to further understand the disease
and potentially create new drugs for after this.
So, in order to do this, in order to turn something like a glucose meter into something
that can sense lithium, we're going to use something like a magnetic bead.
We start off with a magnetic bead that is attached to DNA, which will react specifically
with a target.
And so this DNA can be either an aptamer or it can be a DNAzyme, which is a catalytic
strand of DNA.
And then lastly, that DNA strand will be attached to a protein called invertase.
Now, this DNA strand, when introduced to the target, in my case, it would be lithium, would
cause a release of your invertase protein.
And that invertase protein can then change sucrose into glucose.
Now, this glucose meter will read for glucose, but it will not read sucrose.
So in that way, we can get a direct correlation between the glucose sensor reading and the
amount of target that we initially have.
One of the reasons that we wanted them on magnetic beads is because we want to be able
to remove anything that is non-reactive or the invertase that is still on magnetic beads
from the solution so that we get something that is directly proportional to the target
in glucose reading.
All right, so how are we going to do this and what is the strand of DNA that's going
to be the interlinking basically target reader?
And that's going to be a DNAzyme.
So a DNAzyme is, again, DNA that is catalytic.
What we program it to have is this RNA strand right here because RNA undergoes hydrolysis
more easily.
So these nucleotides are all programmed in, but then we have this region right here that
is random, which means that we basically send it into a company.
They add all the nucleotides together and they will randomly synthesize.
So if you have something like 25 random nucleotides, then it gives you 4 to the 25th different
types of sequences.
So that means each one of these sequences is going to fold a little bit differently
or it's going to interact differently.
And so of these, some of them are going to react with lithium in one way, some of them
are going to react in another.
Some of them will react with calcium, sodium.
There's just a plethora of things that they could do.
So what we do then is if we have this DNA, then we can come back over here and we can
see that once it causes a hydrolysis reaction, that will cause the break of the strands and
that will cause dehybridization over where we have low melting points.
And the two strands can separate.
That would mean the release of a fluorophore if we were going to do a fluorophore quencher
model or it could cause the release of invertase as we would see up here.
So in order to get something or find out what this random region is right in here, then
we can go ahead and use a technique called in vitro selection.
So in vitro selection, again, we start off with something like 10 to the 13 different
types of sequences, so a very high number, and we expose them all to some sort of negative
selection or some sort of conditions that contain ions that we don't want our DNA to
be reactive with.
What that does is it causes, again, cleavage reaction.
So we have two different sizes of DNA that are floating around in solution.
Again, if we take around 20 nucleotides off of something that is about 110 bases, then
we're going to get a significantly shorter strand.
So we can just separate this via gel electrophoresis.
So we separate, then, the things that are reactive with everything we don't want from
the things that are not.
So what happens is we take what is left unreactive, and we react it with our target.
And then let's say that this now reacts with lithium, which is what we want.
We then keep all these sequences that are reactive, and we discard everything we don't
using, again, gel electrophoresis.
And so then we can take everything that was unreactive and use PCR amplification to then
go back into this roundup here with a different set of DNA or a more limited set of DNA and
continue throughout these rounds.
So the progress that I've made on this so far is by going through about 20 rounds of
selection.
I have two different pools, one that has around 25 nucleotides in here and one that has about
50 nucleotides in the random region.
So what we see is a general increase in the amount of DNA that is cleaving in the presence
of lithium to about 10% in the later rounds.
So that means our sequences, or our general pool, has sequences that are responsive to
lithium, which is ideally what we want.
Now if we go ahead and we look at this and we compare it to other monovalent species,
like sodium, potassium, cesium, and rubidium, that's the same concentration of lithium,
we can see that this is clearly more reactive with lithium than it is reactive with other
monovalent species, which means we're heading towards our goal.
Where we can take this then is to go ahead and clone these and sequence them and find
out what exactly is in this region that is making it reactive specifically with lithium.
So my name is Dylan Dogwiss and I'm presenting a project that uses the graphite from pencils
and through a variety of treatments functionalizes it into a supercapacitor.
So here we see a couple of the different treatments that we've gone and performed thus far.
First off we have our annealing treatment, which we found that if we take the graphite
from a pencil, put it into a furnace with flowing argon, anneal that sample at 1100
degrees Celsius for 5 hours, we see a 130,000% increase in the capacitance of that material.
We also studied the effect of composition of the actual graphite itself on the capacitance
of the material. So pencil graphite is actually a little bit misleading because it's not
pure graphite. It is a mixture of graphite and clay. So your standard number 2 pencil
has a certain ratio of clay to graphite so that it can appear on the standardized tests.
So what we did is we went and got drawing pencils that have a higher graphite and they're
softer. We also went and got higher clay ratios, which are a little bit harder and a little
bit lighter. What we saw here kind of predictably was a large increase in energy storage in
high graphite samples. But curiously enough we also saw very well defined peaks of these
curves in the higher clay samples. It's kind of hard to see in this figure because it's
put on the scale of the high graphite, but these show a little bit more defined edges
as to the redox peaks in the C-V curve. A quick explanation of C-V curves really quickly
is it stands for cyclic voltrametry. What we're doing here is we sweep from 0 to 1
volts and we do that because if you go higher than 1 volt you'll split water and get noise
in your data. But we sweep from this electric potential and we measure the current that's
coming out of the solution of these two electrodes. So we have one electrode that's platinum,
that's our working electrode that's supplying the potential and the counter electrode, which
is the thing that we're measuring. When we go along this potential and we see kind of
zero current, that means there's no electron transfer going on between the solution and
the working electrode, the thing we're measuring. Once we start to see it increase at around
0.5 volts, we've hit an electric potential which is allowing for electron transfer and
electron current, so that's just the flow of electrons. We're seeing that current and
we're seeing a charge increase as we go up and then this is the oxidation that happens
and then we sweep back from 1 to 0 and get reduction. So basically we're seeing that
there's a direct correlation between the energy storage of the material and the area of this
curve. Now going back to the original treatments, one other treatment that we did was we grafted
carbon nanofibers onto the surface of this pencil or the pencil graphite. This increased
the surface area, increased the capacitance slightly, but what we were more interested
in was the durability of the material. So we saw with the carbon nanofibers that the
durability of the material after repeated cycles, the capacity dropped off less than
when it was bare and just by itself normal pencil graphite. The last treatment that we
explored was grafting conductive polymer onto the surface of the pencil graphite and what
we did there was graft conductive polypyrrole onto the surface and we saw a 300 percent
increase in capacitance and that is from the original annealing capacitance. So we
improved this great improvement even further. So from this study we've actually explored
a couple of treatments of this carbon material to improve its energy storage for potential
devices such as super capacitors or perhaps fuel cells and in future work we wish to do
some XPS testing as to what is really going on at an elemental level and what is causing
these increases in energy storage. Thank you.
Hi, my name is Kenry. I'm from National University of Singapore. I'm currently a second year
student. So the project that I'm currently working on is titled viscoelastic effects
of silicon gels for cellular traction force measurement at the micro and nano scale. So
basically the objective of this project is to characterize the viscoelasticity of silicon
gels in order to evaluate the suitability for traction force measurement. So normally
when people want to measure traction forces, people tend to use elastic materials with
minimal viscous response. However, in recent years there has been increased use of silicon
gels which is a viscoelastic material for this purpose. And then most of the characterization
work done on silicon gels are performed on bulk materials. However, for most of the cell
traction force assays, only the substrate surface is deformed when cells exert nanonewton
forces over the underlying substrate for a micrometer length scale. So there arises a
need to characterize the viscoelasticity of these silicon gels at the micro and nano
scale. So what we do is that we actually evaluate five different types of gels based on the
different stiffnesses. And then we use atomic force microscope to probe the stiffness of
these materials in order to evaluate whether it exhibits this time dependent and strain
rate dependent responses or not. So based on the available theoretical models like Hertz
model, DMT model, we actually extract the elastic modulus of these gels from the force
indentation curve. And these are some of the results displayed here. After evaluating the
elastic modulus of these gels or the stiffness of these gels, basically we move on to characterize
more about the viscoelastic behavior of these gels. So using the same instrument, atomic
force microscope, we basically characterize the creep response of these five different
types of silicon gels. And based on this VOIC-SLS model, we actually extracted all the
viscoelastic parameters of these silicon gels. And lastly, we seeded fibroblast cells on
these five different types of silicon gels and evaluate whether this traction force exerted
by the adherence cells will induce permanent or non-elastic deformation or not on these
silicon gels. And eventually, we concluded that silicon gels with high stiffness and
elasticity, they basically exhibit short characteristic retardation time and they will be more suited
for self-traction force measurements. Thank you.
So I'm Lee Elapu. I'm from University of Tennessee Health Science Center and I'm a
student faculty over there. So today my poster, it deals with more of magnetic nanoparticle
formulation and human serum protein interactions. So what we did, like this project we started
five years ago to improve the drug delivery and imaging capability of magnetic nanoparticle
formulation. So what we did, like we generated unique double-layered formulation that can
be used for both drug delivery and imaging with antibody guided therapy. So here the
picture, it gives more information about what happens if the nanoparticles are incubated
with human serum because that determines whether the particles can be reached to the tumor
or intended target. So what we did see in this work, so when we incubated nanoparticles
in the human serum, the particles are highly bound to the protein called APOE1, so which
indicates that the particle formulation has more bioavailability or more in the circulation
that can be reached to the tumor for therapy application. And moreover, this particle formulation
size is not altered and also the particles did not induce any hemotoxicity to the human
red blood cell. Additionally, the particles when incubating with the human serum protein,
they did not alter inherent properties such as MRI properties and hyperthermia and other
applications because it has higher magnetization saturation values. So overall, this poster
it speaks like this formulation is like, it has more stable in the human serum and
that can be used for human therapy applications in the near future.
My name is Zainab and I am with the Department of Biochemistry at University of Illinois
at Urbana-Champaign and my PIs are Dr. Tekebha and Dr. Debra Legbin. My project basically
is trying to address the clear gap of knowledge between the single, of how the single molecular
forces act or influence the cell receptors which indirectly or directly influence the
cellular function. To address this, recently HALAB developed DNA nanostructures and we
call them TGT or Tension Gauge Tether. How this work is that if the tension tolerance
of this TGT is less than the force applied by the transmembrane receptor, the TGT ruptures
as it can be seen here and which directly or indirectly influences receptor-regulated
cell functions and a readout for that in our case is the adhesion of cells on this TGT
modified surface. However, if the tension tolerance of these TGTs is greater than the
force applied by the transmembrane receptor, the TGTs remain intact and the receptor-regulated
cellular functions are activated. Another major key player in my project are cadherins.
Cadherins are transmembrane proteins which are involved in cell-cell, which are involved
basically in cell-cell junctions and if there is an aberrancy of cadherin expression, then
we can witness something as majorly wrong as cancer metastasis. How do I combine these
two and try to address the problem is that we have engineered cadherin TGT in our lab
and we are using the system to measure the tension tolerance of cadherin bond. The design
of cadherin TGT is very simple. We have a 22 base pair DNA double strand which is conjugated
to a protein gene which links to any sort of Fc domains to create e-cadherins or any
other proteins for that matter. And then we have a 6 nanometer which prevents the steric
hindrance of the TGT from attaching it to the surface and this has been anchored to
the surface using your travertine biotin. The surface is passivated by PEG. So our preliminary
research showed that the design actually works and that cells are able to adhere on the TGT
modified surfaces. These are the DLD1 cells. However, we are not able to see MDCK cells
and MCF7 cells which are important in cadherin studies to these cadherin TGT modified surfaces.
So we have tried to address this issue and what we have been able to conclude is that
the e-cadherin density on the control surfaces without the TGT is much higher than the e-cadherin
density on the cadherin TGT surface. So currently we are working on increasing the cadherin
density on the e-cad TGT surface. My second aim is to determine the critical tension required
for e-cadherin mediated mechanotransduction. For that we will be using magnetic twisting
cytometry. In this experiment we cover our cells with these magnetic beads that are basically
coated with the ligand of our choice and then we apply a torque on it and if there is a
stiffening response, that is the amplitude of the bead movement decreases, it is a readout
for mechanotransduction as it can be seen here. However, if there is no stiffening response,
no mechanotransduction has happened. So an example of that behavior was seen when we
applied the magnetic bead and the cells were coated with e-cadherin, then we saw a stiffening
response that was a dampening in the amplitude and that was correlated to the increase in
the stiffness of the cell. Lysine, which is a nonspecific molecule, protein and is used
for control. We did not witness any dampening in the amplitude of the bead displacement
which meant that no mechanotransduction has happened. So we will use basically the stiffening
of the bead or the reduction in the amplitude as a readout of our mechanotransduction. We
will be coating our beads with e-cadherin TGT of different tension tolerance and we
will see where we get the stiffening response and we will use that to determine the critical
tension required for cadherin mediated mechanotransduction. The other part of our design is that we will
be using the system to study the crosstalk between integrin and cadherin and the response
of the global mechanotransduction. Our beads would be coated with e-cadherins and our cells
would be coated on surfaces which are functionalized with integrin TGT and then we will see how
does the basically change the activation of the integrin TGT and that's the description
of my project. Some of it is ongoing and some of it has to be done.

